Ridder Titan Genesis (RTGC) Stock Overview
Does not have significant operations. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
RTGC Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Looking to be second time lucky with a game-changing new product
Key Takeaways Unicycive has successfully completed clinical development of its lead asset, Oxylanthanum Carbonate (OLC). OLC has been designed to improve on current phosphate binders by offering better efficacy, fewer pills, and improved tolerability over alternative treatments for hyperphosphatemia chronic kidney disease patients on dialysis.Read more
Ridder Titan Genesis Corp. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.47 |
| 52 Week High | US$0.50 |
| 52 Week Low | US$0.0065 |
| Beta | 0 |
| 1 Month Change | -6.00% |
| 3 Month Change | n/a |
| 1 Year Change | 142.27% |
| 3 Year Change | 581.16% |
| 5 Year Change | 4.44% |
| Change since IPO | -99.90% |
Recent News & Updates
Recent updates
Shareholder Returns
| RTGC | US Pharmaceuticals | US Market | |
|---|---|---|---|
| 7D | 0% | 4.6% | -0.1% |
| 1Y | 142.3% | 29.1% | 13.8% |
Return vs Industry: RTGC exceeded the US Pharmaceuticals industry which returned 25.4% over the past year.
Return vs Market: RTGC exceeded the US Market which returned 10.3% over the past year.
Price Volatility
| RTGC volatility | |
|---|---|
| RTGC Average Weekly Movement | n/a |
| Pharmaceuticals Industry Average Movement | 9.6% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in US Market | 16.2% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: RTGC's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: Insufficient data to determine RTGC's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1988 | n/a | Bruce Thompson | n/a |
Ridder Titan Genesis Corp. does not have significant operations. Previously, it was engaged in the development of whole plant extractions for the cancer and palliative treatments. The company was formerly known as UMF Group Inc. and changed its name to Ridder Titan Genesis Corp. in February 2024.
Ridder Titan Genesis Corp. Fundamentals Summary
| RTGC fundamental statistics | |
|---|---|
| Market cap | US$3.14m |
| Earnings (TTM) | US$4.71k |
| Revenue (TTM) | US$140.97k |
Is RTGC overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| RTGC income statement (TTM) | |
|---|---|
| Revenue | US$140.97k |
| Cost of Revenue | US$0 |
| Gross Profit | US$140.97k |
| Other Expenses | US$136.26k |
| Earnings | US$4.71k |
Last Reported Earnings
Sep 30, 2011
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did RTGC perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/02/06 00:57 |
| End of Day Share Price | 2026/02/03 00:00 |
| Earnings | 2011/09/30 |
| Annual Earnings | 2010/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Ridder Titan Genesis Corp. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.